BYU awarded $852K in ongoing lawsuit with Pfizer

BYU awarded $852K in ongoing lawsuit with Pfizer

Save Story
Leer en espaƱol

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

SALT LAKE CITY (AP) -- A federal magistrate has awarded Brigham Young University more than $852,000 in attorney fees and other costs in an ongoing lawsuit between the school and drugmaker Pfizer Inc.

Magistrate Brooke Wells ruled Wednesday that Pfizer has engaged in repeated delays in the suit.

BYU claims a professor's research provided to Pfizer's predecessor, Monsanto, helped create the anti-inflammatory drug Celebrex. BYU sued Pfizer in 2006 after negotiations didn't produce an agreement.

In the ruling Wells cited abuses and repeated failures in producing documents in the case.

Pfizer spokesman Christopher Loder says the company disagrees with the award of fees but respects the court's ruling. Pfizer says Professor Daniel L. Simmons and his research had nothing to do with the creation of its drug.

BYU spokesman Michael Smart says only that the ruling speaks for itself.

Information from: The Salt Lake Tribune

(Copyright 2009 by The Associated Press. All Rights Reserved.)

Most recent Utah stories

Related topics



Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the Trending 5.
By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

KSL Weather Forecast